BIOTRONIK Neuro acquires spinal cord stimulation IP from Soin Neuroscience

BIOTRONIK Neuro acquired a portfolio of intellectual property related to spinal cord stimulation from Soin Neuroscience. Financial terms were not disclosed. The acquisition builds on a prior research collaboration announced in December 2025.

“Spinal cord stimulation has helped countless patients manage chronic pain without relying on opioids, but there is still enormous room to make the therapy smarter, more personalized, and dynamic.”biospace.com

• 2 sources
• biospace.comBIOTRONIK Neuro Acquires Spinal Cord Stimulation System from Soin Neuroscience - BioSpaceAnnalee ArmstrongJul 16, 2026
• medicaldevice-network.comBIOTRONIK Neuro acquires Soin Neuroscience’s SCS IP portfolioSalong DebbarmaJul 16, 2026

Summarized from public sources; check the original articles before acting on it.